TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14813 · Jun 9

#javascript#ai#cursor#cursor_ai#cursorai#lovable#lovable_dev#roocode#task_manager#tasks#tasks_list#windsurf#windsurf_ai Task Master is a tool that helps manage tasks using AI. It works with different AI models like Claude and supports various providers such as OpenAI and Anthropic. Users can set up tasks, track progress, and even switch between AI models easily. This tool is useful for developers who need to organize their work efficiently and want flexibility in choosing the best AI model for their projects. It helps streamline tasks and improve productivity by automating some processes and providing clear guidance on what to do next. https://github.com/eyaltoledano/claude-task-master

Results

4 similar posts found

Search: #vets

当前筛选 #vets清除筛选
VetPlus Academy

@vetplusacademy · Post #1291 · 01/29/2026, 03:42 PM

¡Tu crecimiento profesional no se detiene! 📈 Estamos diseñando un espacio donde la teoría y la práctica se encuentran para fortalecer tus competencias clínicas. Guías descargables, sesiones en vivo y certificación mensual son solo el comienzo. Mantente conectado. Lo que viene superará tus expectativas ✨ 🌐 Visítanos: vetplusacademy.com 📲 WhatsApp: +58 414 5300397 #VetPlus#Vets#MedVet#EstudiantesVeterinaria#VetPlusUltra

VET's HUB ®

@vets_hub · Post #30255 · 12/07/2025, 03:32 AM

NEWS 🔻𝗪𝗲𝗶𝗴𝗵𝘁 𝗹𝗼𝘀𝘀 𝗱𝗿𝘂𝗴𝘀 𝗳𝗼𝗿 𝗰𝗮𝘁𝘀? 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗶𝗺𝗽𝗹𝗮𝗻𝘁𝘀 𝗶𝗻 𝗰𝗮𝘁𝘀 #Okava_Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new #GLP_1 clinical weight loss study for cats. #MEOW_1, as the study is called, will look to use #OKV_119, a miniature implant, in cats which will deliver the GLP-1, continuously for up to six months. According to #Okava, MEOW-1 is the first-ever weight loss trial using this approach on household pets. Klotsman said the goal would be to file for #FDA approval for the product between 2027 and 2028, and the target is for the product to cost owners an out-of-pocket payment of around $100 per month. Read the full story 👇 https://abcnews.go.com/GMA/Wellness/weight-loss-drugs-cats-company-launches-clinical-trial/story?id=128054236 #feline#cats#pets#petobesity#petcare#okavapharmaceuticals#sanfrancisco#vets#petowners#veterinarians#dvm